rs1131690917

Variant names:

• chr19-1207065-TGGG-T
• rs1131690917
• NM_000455.5:c.155_157delGGG

Your query was ambiguous. Multiple possible variants found:

• chr19-1207065-TGGG-T
• chr19-1207065-TGGG-TG
• chr19-1207065-TGGG-TGG
• chr19-1207065-TGGG-TGGGG
• chr19-1207065-TGGG-TGGGGG
• chr19-1207065-TGGG-TGGGGGG

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1 PM2 PM4_Supporting PP5

The NM_000455.5(STK11):​c.155_157delGGG​(p.Gly52del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

• Frequency: Genomes: not found (cov: 31)
• Consequence: STK11 NM_000455.5 disruptive_inframe_deletion
• Clinical Significance: Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1 U:2
• Conservation: PhyloP100: 9.65

Genes affected

STK11 (HGNC:11389): (serine/threonine kinase 11) The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]

ACMG classification

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

• PM1: In a domain Protein kinase (size 260) in uniprot entity STK11_HUMAN there are 19 pathogenic changes around while only 5 benign (79%) in NM_000455.5
• PM2: Very rare variant in population databases, with high coverage
• PM4: Nonframeshift variant in NON repetitive region in NM_000455.5. Strenght limited to Supporting due to length of the change: 1aa.
• PP5: Variant 19-1207065-TGGG-T is Pathogenic according to our data. Variant chr19-1207065-TGGG-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 428751.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=2}.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
STK11	NM_000455.5	c.155_157delGGG	p.Gly52del	disruptive_inframe_deletion	Exon 1 of 10	ENST00000326873.12	NP_000446.1
STK11	NM_001407255.1	c.155_157delGGG	p.Gly52del	disruptive_inframe_deletion	Exon 1 of 9		NP_001394184.1
STK11	NR_176325.1	n.1291_1293delGGG		non_coding_transcript_exon_variant	Exon 1 of 11

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
STK11	ENST00000326873.12	c.155_157delGGG	p.Gly52del	disruptive_inframe_deletion	Exon 1 of 10	1	NM_000455.5	ENSP00000324856.6
STK11	ENST00000652231.1	c.155_157delGGG	p.Gly52del	disruptive_inframe_deletion	Exon 1 of 9			ENSP00000498804.1
STK11	ENST00000585748.3	c.-82-11349_-82-11347delGGG		intron_variant	Intron 3 of 11	3		ENSP00000477641.2
STK11	ENST00000593219.5	n.155_157delGGG		non_coding_transcript_exon_variant	Exon 1 of 4	3		ENSP00000466610.1

Frequencies

GnomAD3 genomes Cov.: 31

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome Cov.: 31

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Pathogenic:1 Uncertain:2

Revision: criteria provided, conflicting classifications

Submissions by phenotype

Peutz-Jeghers syndrome Uncertain:2

Jul 15, 2021

Genome-Nilou Lab

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Nov 03, 2022

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant, c.155_157del, results in the deletion of 1 amino acid(s) of the STK11 protein (p.Gly52del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 428751). This variant is also known as 153del3. This variant has been observed in individual(s) with Peutz-Jeghers syndrome (PMID: 11389158). -

Hereditary cancer-predisposing syndrome Pathogenic:1

Sep 24, 2015

Ambry Genetics

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The c.155_157delGGG variant (also known as p.G52del) is located in coding exon 1 of the STK11 gene. This variant results from an in-frame deletion of 3 nucleotides at positions 155 to 157, causing the removal of a highly conserved glycine residue at codon 52. This alteration, referred to as 153del3, was previously identified in one individual with a clinical diagnosis of Peutz-Jeghers syndrome (PJS), who was found to have perioral hyperpigmentation as well as hamartomatous lesions in the stomach, duodenum, and colon (Olschwang S et al. J. Med. Genet. 2001 Jun; 38(6):356-60). Based on protein sequence alignment, this amino acid position is highly conserved in available vertebrate species. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -

Computational scores

Source: dbNSFP v4.3

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs1131690917; hg19: chr19-1207064;